---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-041945"
form_type: "8-K"
ticker: "SRXH"
cik: "0001471727"
company_name: "SRx Health Solutions, Inc."
filed_at: "2026-09-09T19:00:27+00:00"
generated_at: "2026-09-09T19:01:09.116979+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# SRX Global gets holder consent for up to $20M stock repurchase plan

## Summary
- On Sept 8, 2026, SRX Global and Required Holders entered a Limited Consent and Amendment Agreement.
- Consent allows repurchase of up to 10M shares or 50% of outstanding, max $20M, through July 7, 2027.
- Agreement amends definition of Required Holders in the Aug 27, 2026 Securities Purchase Agreement.
- Company previously sold 3,579 Series C preferred shares for $2.825M on Aug 27, 2026.

## SEC filing metadata
- accession: 0001493152-26-041945
- form_type: 8-K
- ticker: SRXH
- cik: 0001471727
- company_name: SRx Health Solutions, Inc.
- filed_at: 2026-09-09T19:00:27+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1471727/000149315226041945/0001493152-26-041945-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1471727/000149315226041945/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-041945
- JSON: https://secwatch.observer/filing/0001493152-26-041945.json
- Plain text: https://secwatch.observer/filing/0001493152-26-041945.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.